Physician profile
Hamid Mumtaz
NPI 1023020500
$71,794.06
in general payments reported to CMS, 2019-2025
34 companies · $9,144 in 2025
The $9,144 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $5,584 · 2021: $8,203 · 2022: $6,710 · 2023: $26K · 2024: $14K · 2025: $9,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $30K · Food and Beverage: $8,291 · Travel and Lodging: $7,452 · Consulting Fee: $3,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $30,250.00 |
| Food and Beverage | $8,291.07 |
| Travel and Lodging | $7,451.74 |
| Consulting Fee | $3,710.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $36,947.79 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $15,708.90 | 2020-2025 | Coseal, Hemopatch, Peri-Strips Dry |
| Atricure, INC. | $3,834.45 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Ethicon INC. | $3,020.81 | 2020-2022 | |
| Tela Bio, INC. | $2,755.52 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $1,826.56 | 2021-2024 | Endoflip, Nexpowder |
| Medical Device Business Services, INC. | $1,414.16 | 2021-2024 | Linx Reflux Management System, Echelon Flex |
| Boston Scientific Corporation | $1,017.53 | 2019-2020 | |
| Inari Medical, INC. | $737.14 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon US, LLC | $712.10 | 2020-2024 | Stratafix, Ethicon, Surgiflo Hemostatic Matrix |
| Cvrx, INC. | $670.64 | 2022-2025 | Barostim Neo System |
| On Target Laboratories, INC | $501.31 | 2025 | Cytalux |
| Arthrex, INC. | $482.45 | 2025 | |
| Davol INC. | $319.70 | 2019-2025 | Phasix Mesh |
| Astrazeneca Pharmaceuticals LP | $302.36 | 2021-2024 | Tagrisso |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $162.03 | 2019 | |
| Stryker Corporation | $159.17 | 2025 | Clottriever Bold Catheter, 1788 |
| Biom'Up France Sas | $149.10 | 2020 | |
| Ets Wound Care LLC | $136.87 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Pinnacle Biologics, INC | $136.03 | 2024 | Photofrin |
| Penumbra, INC. | $133.04 | 2022 | |
| United Therapeutics Corporation | $102.00 | 2024 | |
| Bard Access Systems, INC. | $100.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $95.25 | 2023 | Zeposia |
| Stability Biologics, LLC | $72.52 | 2021 | |
| Conmed Corporation | $66.57 | 2020 | |
| Coastal Medical Technologies LLC | $54.28 | 2024 | |
| Lemaitre Vascular, INC. | $48.62 | 2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Coloplast Corp | $37.31 | 2023 | Titan |
| Axonics, INC. | $31.45 | 2023 | Axonics, Bulkamid |
| Acera Surgical, INC. | $22.44 | 2024 | Restrata Wound Matrix |
| Laminate Medical Technologies INC. | $20.00 | 2025 | Vasq |
| Lexington Medical, INC. | $13.87 | 2022 | |
| Elutia, INC. | $2.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Mumtaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.